COOPER COS INC/THE (COO) Stock Overview
USA - NASDAQ:COO - US2166485019 - Common Stock
COO Key Statistics, Chart & Performance
The current stock price of COO is 71.75 USD. In the past month the price increased by 4.65%. In the past year, price decreased by -32.22%.
COO Latest News, Press Relases and Analysis
COO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ALC | ALCON INC | 24.77 | 37.39B | ||
| SOLV | SOLVENTUM CORP | 11.66 | 12.30B | ||
| ALGN | ALIGN TECHNOLOGY INC | 14.15 | 9.65B | ||
| BLCO | BAUSCH + LOMB CORP | 36.19 | 5.38B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 22.62 | 4.90B | ||
| LNTH | LANTHEUS HOLDINGS INC | 8.97 | 3.90B | ||
| ICUI | ICU MEDICAL INC | 15.97 | 2.97B | ||
| XRAY | DENTSPLY SIRONA INC | 7.64 | 2.61B | ||
| HAE | HAEMONETICS CORP/MASS | 10.83 | 2.43B | ||
| UFPT | UFP TECHNOLOGIES INC | 22.93 | 1.53B | ||
| ESTA | ESTABLISHMENT LABS HOLDINGS | N/A | 1.52B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.34B |
Related stock screener links
About COO
Company Profile
The Cooper Cos, Inc. operates as a medical device company. The company is headquartered in San Ramon, California and currently employs 16,000 full-time employees. The firm operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. The company also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
Company Info
COOPER COS INC/THE
6101 Bollinger Canyon Road, Suite 500
San Ramon CALIFORNIA 94583 US
CEO: Albert G. White III
Employees: 16000
Phone: 19254603600
COOPER COS INC/THE / COO FAQ
What does COOPER COS INC/THE do?
The Cooper Cos, Inc. operates as a medical device company. The company is headquartered in San Ramon, California and currently employs 16,000 full-time employees. The firm operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. The company also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
What is the stock price of COOPER COS INC/THE today?
The current stock price of COO is 71.75 USD. The price decreased by -1.51% in the last trading session.
Does COO stock pay dividends?
COOPER COS INC/THE (COO) has a dividend yield of 0.02%. The yearly dividend amount is currently 0.
How is the ChartMill rating for COOPER COS INC/THE?
COO has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
How is the valuation of COOPER COS INC/THE (COO) based on its PE ratio?
The PE ratio for COOPER COS INC/THE (COO) is 17.85. This is based on the reported non-GAAP earnings per share of 4.02 and the current share price of 71.75 USD.
Can you provide the growth outlook for COOPER COS INC/THE?
The Revenue of COOPER COS INC/THE (COO) is expected to grow by 4.74% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the number of employees for COOPER COS INC/THE?
COOPER COS INC/THE (COO) currently has 16000 employees.
COO Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to COO. When comparing the yearly performance of all stocks, COO is a bad performer in the overall market: 87.19% of all stocks are doing better.
COO Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to COO. While COO has a great profitability rating, there are some minor concerns on its financial health.
COO Financial Highlights
Over the last trailing twelve months COO reported a non-GAAP Earnings per Share(EPS) of 4.02. The EPS increased by 13.96% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.08% | ||
| ROA | 3.29% | ||
| ROE | 4.88% | ||
| Debt/Equity | 0.3 |
COO Forecast & Estimates
24 analysts have analysed COO and the average price target is 87.08 USD. This implies a price increase of 21.36% is expected in the next year compared to the current price of 71.75.
For the next year, analysts expect an EPS growth of 11.8% and a revenue growth 4.74% for COO